Saol Therapeutics Acquires Three Hyperimmune Products from Aptevo Therapeutics

DFW Capital Partners is pleased to announce that its existing portfolio company, Saol Therapeutics, has acquired to acquire three marketed hyperimmune products, WinRho® SDF (Rh0(D) Immune Globulin Intravenous (Human)), HepGam B® (Hepatitis B Immune Globulin Intravenous (Human)) and VARIZIG® (Varicella Zoster Immune Globulin (Human)) from Aptevo Therapeutics Inc. (Nasdaq: APVO). The deal includes both upfront… Read more »

Evolution Research Group acquires Endeavor Clinical Trials

DFW Capital Partners is pleased to announce that its existing portfolio company, Evolution Research Group (“ERG”), has acquired Endeavor Clinical Trials (“ECT”), of San Antonio, Texas. ECT has over 20 years of experience conducting over 185 clinical trials, specializing in post-operative pain, neuropathic pain, podiatry, and vaccine research, among others. Endeavor Clinical Trials is comprised… Read more »

DFW Capital Partners Combines LRI and RTS into Integrated Efficiency Solutions

DFW Capital Partners (“DFW”) today announced that Integrated Efficiency Solutions (“IES”), a new holding company, has continued its commitment to the energy solutions market with its third investment. On June 30, 2017, IES acquired Retro-Tech Systems (“RTS”) as a wholly owned subsidiary. RTS, which includes RTS Lighting, RTS Water, RTS Utility Metering, and RTS Building… Read more »

Superior Controls Merges with Banks Integration Group

DFW Capital Partners is pleased to announce that its existing portfolio company, Superior Controls, a leading control system integrator of custom industrial automation and IT solutions, has merged with Banks Integration Group (“Banks Integration”), a leading systems integrator headquartered in Vacaville, CA outside San Francisco.  The combination, which is the first investment of its kind for… Read more »

DFW Capital Partners announces an investment in Children’s Dental Health Associates

DFW Capital Partners (“DFW”) is pleased to announce that it recently completed an equity investment in Children’s Dental Health Associates (“CDHA Holdings, LLC” or “CDHA”). CDHA is a dental service organization, providing management and support services to pediatric dentists throughout the state of Pennsylvania. The Company’s CEO and founder, Dr. Eric Felix, management, and each… Read more »

DFW Capital Partners closes strategic investment in LRI

DFW Capital Partners (“DFW”) announced today a strategic investment in Lighting Retrofit International, LLC (“LRI” or the “Company”). LRI is a portfolio company of Arborview Capital (“Arborview”), which previously invested into LRI in 2010. LRI is DFW’s first portfolio investment in its newest fund, DFW Capital Partners V, LP, which held its final closing in… Read more »

Evolution Research Group acquires Clinical Pharmacology of Miami, LLC

DFW Capital Partners is pleased to announce that its existing portfolio company, Evolution Research Group (“ERG”), has acquired Clinical Pharmacology of Miami, LLC (“CPMI”), a clinical investigative site conducting research protocols for pharmaceutical/biotech companies and a leader in specialty population Phase I trials. With this acquisition, ERG has now completed three strategic add-on acquisitions since… Read more »